Oct 3 (Reuters) - VALBIOTIS SAS ALVAL.PA :
* VALBIOTIS - VALEDIA®: KEY DATA SUPPORTING THE SUBMISSION
OF A
HEALTH CLAIM, SELECTED AND PRESENTED AT THE EASD 54TH CONGRESS
IN BERLIN
* DATA OBTAINED IN CLINICALLY RELEVANT MODELS, RELATIVE TO
MECHANISM OF ACTION
* NEW RESULTS, INCLUDING A MAINTAINED SECRETION OF INSULIN
BY
PANCREAS,
* IN VIVO CHARACTERISATION OF MULTI-TARGETED MECHANISM OF
ACTION
SHOWN TO IMPACT 5 KEY ORGANS
Source text for Eikon: ID:nBw38FG3Ja
Further company coverage: ALVAL.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))